CENGILD | CENGILD MEDICAL BERHAD

0.240 (-2.04%)

T-O (am): 0.000 (08:59:00)
Last updated: 15:08

Fundamental This feature is limited for iSaham clients only
Technical This feature is limited for iSaham clients only
Total Score This feature is limited for iSaham clients only

CENGILD | CENGILD MEDICAL BERHAD


CENGILD Fundamental Trend

FCON: This feature is limited for iSaham Pro only | Sharpe Ratio: This feature is limited for iSaham Pro only | LTS: This feature is limited for iSaham Pro only


Chart:

CENGILD Quarter Reports

Select columns required and click "Update" to save your preferences

CENGILD Historical Dividends

CENGILD Financial Ratios

EPS 1.38 sen
Trailing PE (Sector Median: 26.7) 17.3
PEG 17.3
Altman Z 1.8
Beaver -0.062
Current Ratio 8.08
Debt-Equity (DE) Ratio 0.24
FCF Yield -1.89 %
Revenue QoQ -9.48 %
Revenue YoY 25.68%
Profit QoQ -26.39 %
Profit YoY 0.75 %
Profit Margin (Sector Median: 8.0) 15.21 %
ROE (ROIC: 10.76) 10.76 %
Dividend Per Share (DPS) 0.97 sen
Dividend Yield (DY) 4.04 %

CENGILD Adjusted Financial Ratios

Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports

EPS
Trailing PE (Sector Median: 26.7)
Profit QoQ
Profit YoY
Profit Margin (Sector Median: 8.0)
ROE (ROIC: 10.76)
Altman Z

CENGILD Fair Value

Weighted Average Fair Value: This feature is limited for iSaham Pro only

Discounted Cash Flow (DCF) 5% Growth This feature is limited for iSaham Pro only
Discounted Cash Flow (DCF) 10% Growth This feature is limited for iSaham Pro only
Relative Valuation This feature is limited for iSaham Pro only
Graham Formula This feature is limited for iSaham Pro only
Graham Number This feature is limited for iSaham Pro only
Net Tangible Asset (NTA) 0.14
Consistent QR FV This feature is limited for iSaham Pro only
The Fair Value numbers are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The figures shown here should be taken as educational purposes only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Forward PE FV Calculator
Latest Profit (adjusted) [M] 2.94
Expected Profit (Next QR) [M]
Expected Profit (After QR above) [M]
Expected Profit (After QR above) [M]
Estimated Fair Value
Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 0
Expected Revenue (M) 0
Expected Growth (%) 0
The Fair Value calculated using this calculators are not, and must not be construed to be, any recommendation, offer or invitation to buy or sell any securities, futures contracts or any other instrument. The purpose of this tool is to help investor to quickly calculate their own expected Fair Value based on their own research

CENGILD Directors Share Purchases (Beta)


DR CHONG SU-LIN reduced 100000.0 units announced on 09 Jan 2023 at ~RM0.49

CENGILD Summary


Market Cap: 199 M.

Market Cap Class: Micro caps

Number of Shares: 832 M.

Adjusted Float: 60.2%.

Stock highly correlated with

ECA (95%)

BINACOM (90%)

PRG (90%)

ASTRO (89%)

Cengild Medical Berhad, incorporated in 2021 and headquartered in Kuala Lumpur, Malaysia, specializes in gastrointestinal and liver disease care, with a strong focus on obesity management and related specialties. Operating through its flagship Cengild G.I. Medical Centre, the company offers a wide range of services including gastroenterology, hepatology, gastrointestinal surgery, bariatric surgery, oncology, cardiology, urology, and ENT. It also provides diagnostic imaging, 24-hour emergency care, laboratory services, and outpatient treatments supported by multidisciplinary medical teams. Cengild’s operations are anchored by two main business segments, Consultant Services and Medical Management Services which delivered through state-of-the-art facilities, complemented by satellite primary care clinics under the Poliklinik CGI brand.

Sectors: Healthcare, Health Care Providers, Penny Stocks

Code: 0243

Website: https://www.cengild.com/

Related Links: Bursa | Annual Report | Announcement

Warrant Info:

No warrants listed

CENGILD Top Shareholdings

Updated on 2-Oct-2023

Shareholder % Value (M)
Dato' Dr. Tan Huck Joo 16.18% 32.34
Anne Marie Loh Foong Han 9.64% 19.27
Emeritus Professor Dato' Dr Goh Khean Lee 7.23% 14.45
Dr. Mohamed Akhtar Bin Mohamed Ditali Qureshi 6.76% 13.51
Tan Kar Tek 4.83% 9.66
Ramesh A/L K Gurunathan 4.73% 9.46
Ong Siew Kuen 3.87% 7.74
Medic Quest Sdn Bhd 3.48% 6.96
Tony Tan Choon Keat 3.28% 6.56
Transmetro Sdn Bhd 2.81% 5.62
Tan Soon Wah 1.59% 3.18
Tang Vee Mun 1.57% 3.14
Koon Poh Keong 1.56% 3.12
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.
This calculator uses Malacca Securities (M+) cash upfront rate (min RM 8 or 0.08%) for all brokerage fee calculation.